Bacteremia Lower respiratory Upper respiratory Intra-abdominal infections Skin infections Meningitis STDs Sepsis UTI Other
Use Of Pharmacokinetics-Pharmacodynamics To Support Oritavancin Dose Selection For Patients With Complicated Skin And Skin-Structure Infection
S. M. Bhavnani, D. Lehoux, C. M. Rubino, G. Moeck, O. O. Okusanya, A. Forrest, T. R. Parr, Jr., P. G.
Global Susceptibility Patterns of E. coli from Intra-Abdominal Infections to Ertapenem and Comparators SMART 2008
R. Badal, S. Bouchillon, A. Johnson, M. Hackel, D. Hoban
Low Recurrence Rate Among Patients with C. difficile Infection Treated with Fidaxomicin
Yoav Golan, MD, MS
Community-versus hospital-onset Clostridium difficile infections: Prevalence on admission and incidence in U.S. hospitals, 2007-2008
Marya D. Zilberberg, MD, MPH
Ampicillin Enhances the Activity of Daptomycin by Alteration of Surface Charge in Vancomycin-Resistant Enterococcus faecium
George Sakoulas, MD
The pharmacodynamics of Telavancin against Vancomycin susceptible MRSA and Vancomycin intermediate S.aureus strains
AR Noel, KE Bowker, SG Tomaselli, HC Elliott, AP MacGowan
Evaluating the Efficacy of Anti-Infective Endotracheal Tubes (ETT) in Preventing Biofilm Colonization (BC) of Multidrug-Resistant Bacteria (MDRB) Associated with Ventilator-Associated Pneumonia (VAP)
I.I. Raad, R. Hachem, T. Dvorak, R. Reitzel
Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Treated with Vancomycin
Ravina Kullar, PharmD
Permeability of the Blood Brain Barrier (BBB) to Amphotericin B (AMB) is Focally Increased in Experimental Hematogenous Candida Meningoencephalitis (HCME)
Vasilios Pyrgos, M.D.